Home » Topics » Regulatory » Patents

Patents
RSS

Androgen receptor-targeting PROTACs synthesized at Arvinas Operations

July 25, 2022

National Institute of Pharmaceutical R&D discovers compounds for diseases caused by toxic aldehydes

July 25, 2022

Newsoara Biopharma presents new PLK1 inhibitors

July 25, 2022

BioWorld MedTech Patent Highlights: Week 28

From Current Patent Gazette

July 22, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

MEKanistic Therapeutics identifies new PI3K and/or EGFR inhibitors

July 22, 2022

University of California presents new CYP3A4 inhibitors

July 22, 2022

Gilead Sciences synthesizes new PADI4 inhibitors

July 22, 2022

Genzyme discloses new CSF-1R inhibitors

July 22, 2022

NiKang Therapeutics patents new PROTACs for cancer

July 22, 2022

Hong Kong Baptist University divulges new antiviral compounds

July 21, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...